Honored to help introduce the Crow’s Nest® Biopsy Catchment System at CAP Product Theater in Las Vegas. As PI of the Hoag Hospital validation study, I’ve seen its potential to reduce insufficient samples and repeat biopsies. I expect to one day use it routinely in my practice.
1
81
Supported an interventional radiologist in Japan on a DVT case using the ClotTriever system, which pulls the clot out through a small access site instead of relying on drugs to dissolve it. I was in California, so: 1am–3am PT. Tiring? Yes. Rewarding? Absolutely.
Previewed at #SIR2026 in Toronto alongside our 120-patient Hoag series; first time sharing the actual histology. Calcein-AM / EthD-1 staining, ImageJ quantification, constructs held at 37°C. Destroying tumor cells in the tract is within reach.
1
3
138
We have never been better at treating DVT. We are not much better at finding it.
Diagnosis is the rate-limiting step — and missing it costs patients a PE or years of post-thrombotic syndrome.
My IAC webinar on venous ultrasound + intervention in DVT:
youtube.com/watch?v=j_f2rCEm…
96
Missed proximal DVT drives PE, mortality, and post-thrombotic syndrome.
My ISET 2026 talk: venous duplex is a decision point, not a checkbox. Abnormal waveforms are telling you about anatomy you aren't imaging.
Will discuss further at ISET 2027.
hmpgloballearningnetwork.com…
1
72
Pneumothorax is why a diagnostic lung biopsy can become an admission.
New case series: 5 CT-guided core biopsies with the SinglePass electrocautery device. Zero pneumothorax, no 30-day complications.
Read here: pubmed.ncbi.nlm.nih.gov/4245…
Disclosure: SinglePass advisor/officer
Bleeding risk decides who gets a medical liver biopsy — and who goes transjugular instead.
New series: 5 coaxial biopsies closed with @ SinglePass electrocautery. No bleeding, no complications at 30 days.
Disclosure: SinglePass advisor/officer
pubmed.ncbi.nlm.nih.gov/4118…
Untreated DVT can become a debilitating chronic disease. Take Mark, for example: chronic DVT in his leg and pelvis left him with a non-healing ulcer. Thrombectomy restored blood flow he hadn’t had in decades. Watch his story: youtube.com/watch?v=Cq5w_3K5…
102
Bleeding is a real risk in core needle biopsy- up to 7% in renal biopsies and 11% in liver. The SinglePass device delivers 100°C via electrocautery to seal the tract, lowering bleeding risk. Watch the technique here: youtube.com/watch?v=sNnsJ2rX…
1
2
98
Missed or misdiagnosed DVT raises the risk of post-thrombotic syndrome (PTS) — impaired function, lower quality of life, even leg ulcers. Duplex imaging is key for both. More proximal vein focus, timely follow-up, and IR referral can change outcomes. More: hmpgloballearningnetwork.com…
1
115
Kidney biopsy is essential but carries bleeding risk: hematuria in ~4%, hematomas up to 11%, and severe bleeding needing transfusion in ~1.6%. Risk factors: kidney dysfunction, uncontrolled HTN, anemia, low platelets, blood thinners. Careful selection & monitoring reduce risk.
1
97
Proud to share our multi-center study: SinglePass electrocautery for biopsy tract closure (n=120) showed 0% post-procedural bleeding, technical issues, and device-related adverse events after biopsy. sciencedirect.com/science/ar…
Disclosure: I'm a SinglePass consultant.
Alex Misono, MD, MBA, RPVI retweeted
Submit your abstract today!
The SIR 2027 Annual Scientific Meeting call for abstracts is now open. Take the chance to showcase your research on the biggest #IR stage in North America.
Learn more and submit your research today: sirmeeting.org/
#SIR27LA
Alex Misono, MD, MBA, RPVI retweeted
ERAS applications are open for the IR independent residency on Monday! Find us under Baptist Health South Florida/Florida International University #MedEd @SIRRFS @schiro_md @RajNarayanan67
Alex Misono, MD, MBA, RPVI retweeted
⚕️ Register now for the upcoming Industry Insights session with @singlepass_! This sponsored webinar will take place on Oct. 21 at 8:30 p.m. ET. Be sure to join us for information about current clinical challenges with biopsies. brnw.ch/21wWk97
Alex Misono, MD, MBA, RPVI retweeted
Miami Vascular has an unexpected opening for a 1yr (prior ESIR)& 2yr (non-ESIR) IR residency position. An exceptional opportunity to train in cutting edge IR & IO! Contact the PD @schiro_md
@SIRspecialists
Alex Misono, MD, MBA, RPVI retweeted
An Update on the Data and Devices for the Treatment of DVT. Watch as Dr Marko, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
hubs.ly/Q03wkRrF0
Alex Misono, MD, MBA, RPVI retweeted
After Mark experienced a serious motorcycle accident, his life became fraught with health challenges, including blood clots and a #DVT that left him longing for the adventurous life he once had. Initial undertreatment of the DVT eventually led to the development of a wound that left Mark living life on the sidelines. It wasn't until Drs. Gurpreet Dhillon and Alexander Misono teamed up that Mark began to feel like himself again.
More on #ClotTriever: bit.ly/4aeZ9Ta
#ClotTriever #InariMedical #PatientStory #PatientsFirst #BloodClotAwareness #LifeWithoutClot
Alex Misono, MD, MBA, RPVI retweeted
Read all about Dr Christopher M. Harnain's #ISET2025 presentation on #venous compression syndromes from the ISET Newsroom.
okt.to/yWk4Iq @chrisharnain
Alex Misono, MD, MBA, RPVI retweeted
Thank you, Interventional Radiologists! We are so grateful for your leadership and partnership. #SIOVegas #iRad @SphereVegas @SIO_Central























